The Pharmacy Council of Nigeria (PCN) has strongly refuted allegations made in a recent media report that suggested its involvement in the distribution of counterfeit drugs. The Council dismissed the claims as “baseless” and “misleading,” emphasizing that the report was a serious misrepresentation of facts.
The PCN is demanding an immediate retraction and a public apology from the television station responsible for the report, accusing it of violating broadcasting ethics and tarnishing the Council’s reputation. The controversy arose from a press interview given by the Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC). The PCN asserted that the comments made in the interview were taken out of context and did not, in any way, implicate the Council in illicit drug distribution. Rather, the interview highlighted the joint efforts of both regulatory agencies in tackling illegal drug markets and counterfeit medicines.
To further clarify its position, the PCN reiterated its longstanding collaboration with NAFDAC in enforcing pharmaceutical regulations. It pointed out that the Council had spearheaded the closure of over 50,000 unauthorized drug outlets across Nigeria, including major markets such as the Sabon Gari Open Drug Market in Kano. The Council also explained that the relocation of traders to the Coordinated Wholesale Centre (CWC) was part of a structured effort to streamline the drug distribution system in line with regulatory standards.
The PCN criticized the television station for misinterpreting the Director-General’s remarks, arguing that the report did not align with the actual content of the interview. It referenced the Nigeria Broadcasting Code (6th Edition, 2016) and stated that the station’s actions contradicted the ethical standards required in journalism. The Council maintained that the NAFDAC Director-General had only provided historical context regarding the regulation of Patent and Proprietary Medicines Vendors (PPMVs), outlining past inconsistencies that led to challenges in the drug supply chain. The PCN insisted that these remarks did not implicate it in any form of wrongdoing.
Expressing disappointment with the misleading report, the PCN urged the media to uphold professionalism, especially when reporting on sensitive issues like public health. It reassured Nigerians of its unwavering commitment to ensuring the availability of safe and effective pharmaceutical services. The Council reaffirmed its dedication to working with NAFDAC and other relevant stakeholders to combat the sale of counterfeit medicines and regulate pharmaceutical practices across the country.
The PCN also expects NAFDAC to issue a clarification to dispel the misinformation contained in the report. It encouraged the public to rely on accurate information rather than misleading headlines. The Council reiterated that its enforcement efforts remain robust, and its collaboration with NAFDAC is crucial in sustaining the fight against illegal drug markets in Nigeria.
Furthermore, the PCN highlighted its recent regulatory activities, including the closure of illegal pharmacies and PPMVs in various locations, such as the Federal Capital Territory (FCT). The Council emphasized that while NAFDAC oversees drug registration and quality control, the PCN is responsible for regulating pharmaceutical practice, training pharmacy professionals, and overseeing the operations of pharmacy technicians and medicine vendors.
In conclusion, the PCN reaffirmed its crucial role in safeguarding public health and vowed to continue its enforcement actions against unauthorized drug sales while strengthening its partnership with NAFDAC.